Status
Conditions
Treatments
About
The investigators hypothesize that the use of a personal hand hygiene system (SafeHavenTM) by anesthesia providers in the adult operating room, combined with a novel infectious pathogen tracking system (OR PathTrac) will decrease participant exposure to pathologic bacteria in the adult operating room.
Full description
This will be a prospective, single center, unmasked, controlled before and after study.
Intervention Arm: Use of SafeHaven hand hygiene system in the operating room
Control Arm: Standard of care hand hygiene
Operating Room Selection: Two patients (case-pair) having surgery in a serial manner in a randomly selected operating room will be evaluated for detection of pathogenic bacteria. The operating room for investigation will be randomly selected through the following process:
The goal of the study is to map transmission of bacteria through the operating room and compare mapping with the SafeHaven Hand Hygiene system to mapping without the SafeHaven Hand Hygiene system. Thus, case-pairs will be randomized to the same assignment. For example, subject 1 and 2 will have surgery in South Operating Room 8 and both will be randomized to the control group. The first 10 case-pairs will be assigned to the control arm and the second 10 case-pairs will be assigned to the intervention arm.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patient Inclusion Criteria:
Patients ≥ 18 years of age having surgery in an adult operating suite at the research center involving the following specialties: orthopedics/spine, orthopedics/total joint, gynecology/oncology, colorectal, open vascular, and open urological, general abdominal, acute care, cardiothoracic, and plastic/breast.
Patient Exclusion Criteria:
Anesthesia Provider Inclusion Criteria:
• Faculty physicians, resident physicians, or certified registered nurse anesthetists that provide care for adults having surgery at the research center.
Anesthesia Provider Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Brandon M Togioka, MD; Sydney Rose, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal